RxDoctor Payments Data

Kamila Osypiuk, OD

Optometrist · North Smithfield, RINPI 1801588280

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 22 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 8 manufacturers reported payments, led by Tarsus Pharmaceuticals, Inc. at 34.9% of the total. 2025 is the largest year on record at $362, more than ten times the $22 reported in 2023. That places this record below the midpoint for optometrist clinicians in RI, where the typical reported total is $618.

$421in general payments, 2019–2025

Across 22 payments — averaging $19.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Tarsus Pharmaceuticals, Inc.$147
  • Alcon$109
  • Oyster Point Pharma, Inc.$48
  • AbbVie$32
  • Johnson & Johnson Vision Care, Inc.$23
  • Heidelberg Engineering, Inc.$22
  • plus $39 from 2 others

What the payments were for

  • Food & beverage$421100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$421 in reported general payments places this provider in the 40th percentile of 226 optometrist providers in Rhode Island.

See all optometrist providers in Rhode Island →

Medicare billing

Part B allowed, 2024
$3,772
Medicare patients
19
Services billed
218

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other optometrist in North Smithfield

See the full list for Rhode Island →

Where these figures come from

Is this you, or does something look wrong? →